Skip to main content

Table 5 Univariate analysis and multivariate analysis of overall survival in 120 gastric cancer patients

From: Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients

Variables

Univariate analysis

Multivariate analysis

Hazard Ratio

95% CI

P value

Hazard Ratio

95% CI

P value

Sex

1.15

0.70–1.89

0.58

1.03

0.60–1.77

0.91

Age

0.93

0.59–1.46

0.75

0.76

0.45–1.29

0.31

Tumor size

0.94

0.47–1.90

0.87

0.77

0.35–1.71

0.52

Differentiation

1.30

0.72–2.37

0.38

1.07

0.54–2.14

0.84

Tumor location

1.09

0.68–1.75

0.71

1.10

0.54–2.14

0.84

Depth of invasion

1.49

0.80–2.76

0.21

1.81

0.76–4.33

0.18

LN metastasis

1.31

0.73–2.34

0.36

1.31

0.62–2.79

0.48

Distant metastasis

0.83

0.26–2.63

0.75

0.66

0.97–4.45

0.67

TNM stage

1.30

0.77–2.19

0.33

0.70

0.30–1.63

0.41

HER2 expression

1.61

0.94–2.74

0.08

5.98

0.97–36.72

0.054

HER3 expression

2.20

1.38–3.52

0.001

1.82

0.93–3.57

0.08

HER2-HER3 co-expression

1.56

0.88–2.75

0.13

6.21

0.95–40.89

0.057

Akt expression

1.79

1.04–3.08

0.04

1.64

0.87–3.12

0.13

p-Akt expression

1.42

0.87–2.27

0.15

0.88

0.46–1.68

0.69

mTOR expression

1.33

0.84–2.11

0.22

1.14

0.64–2.03

0.67

p-mTOR expression

1.88

1.19–2.99

0.01

1.47

0.75–2.87

0.26